+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995396
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiac Marker Testing Market grew from USD 5.10 billion in 2023 to USD 5.50 billion in 2024. It is expected to continue growing at a CAGR of 7.90%, reaching USD 8.69 billion by 2030.

The prevalence of cardiovascular diseases and need for effective diagnostics has increased the adoption of cardiac markers worldwide. The rise of point-of-care testing for cardiac markers has significantly increased the screening of cardiovascular diseases. The initiatives encouraging early cardiovascular disease detection have also contributed to market growth. However, the incidences of product recalls of cardiac marker testing solutions may limit its market adoption. The concerns associated with inaccuracy and limited specificity of cardiac market testing are also challenging factors for the market growth. Moreover, the advancements in testing technologies and the integration of new biomarkers are creating attractive opportunities in the market. Increasing consumer preference towards personalized medicine and the introduction of tailored cardiac marker testing are expected to witness significant growth in upcoming years.

Regional Insights

In the Americas region, the cardiac marker testing market has been flourishing with advancements in technology and the escalating prevalence of cardiovascular diseases. Several local companies and start-ups in major countries such as the United States, Canada, and Brazil, have been focusing on developing and introducing cost-effective and portable devices for effective cardiac assessment. In the Europe region, the cardiac marker testing market has been extensively driven by the increasing number of cardiovascular diseases, the aging population, and the well-established healthcare infrastructure. The cardiac marker testing market in the Middle East and Africa has been significantly impacted due to the rising awareness about coronary people diseases and the expansion of healthcare services. Cardiac marker testing market has been growing at an accelerated rate in APAC countries including China, India, and Japan due to the surge in healthcare services and the significant presence of major companies. The government support in terms of investments for healthcare research and development has led to an increase in innovations in cardiac testing methods.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Cardiac Marker Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Prevalence of cardiovascular diseases and need for effective diagnostics
  • Rise of point-of-care testing for cardiac markers worldwide
  • Initiatives encouraging early detection and screening of cardiovascular diseases

Market Restraints

  • Adverse recalls of cardiac marker testing products

Market Opportunities

  • Advancements in testing technologies and integration of new biomarkers
  • Shift toward personalized medicine and introduction of tailored cardiac marker testing

Market Challenges

  • Concerns associated with inaccuracy and limited specificity of cardiac marker testing

Market Segmentation Analysis

  • Product: Significance of diagnostic instruments in cardiac marker testing
  • Biomarker: Rising utilization of Troponin biomarker for cardiac assessment
  • Type of Testing: Increasing adoption of Point-of-Care testing
  • Disease: Extensive applications of cardiac marker testing in myocardial infarction

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiac Marker Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiac Marker Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays

Mindray, a provider of medical devices and solutions, launched two advanced cardiac biomarkers, high-sensitivity troponin I (hs-cTnI) and NT-proBNP, for diagnosing and managing cardiovascular diseases (CVDs). The NT-proBNP assay demonstrates exceptional precision, with a coefficient of variation (CV) of less than or equal to 5%. Furthermore, it eliminates interference from 55 medications commonly used to treat heart diseases. This makes it a highly reliable tool for detecting and managing heart failure. Mindray's commitment to innovation in cardiac marker testing ensures accurate and efficient diagnosis and management of CVDs.

NOWDx and AeenaDx Announce Merger

NOWDx and AeenaDx have merged to form NOWDiagnostics (NOWDx). NOWDx is strategically positioned to cater to the global point of care (POC) and over-the-counter (OTC) diagnostics market. The main areas of focus for NOWDx include the commercialization of tests for Syphilis and Strep, as well as ongoing development for infectious diseases, women's health, drugs of abuse, cardiac markers, and cancer. The company is committed to delivering accurate and reliable diagnostic solutions to healthcare providers and patients worldwide.

Pathkind Labs, Roche Diagnostics Partner to Release Cardiac Biomarker

Pathkind Labs and Roche Diagnostics are partnered to introduce NTProBNP, a cardiac marker used for detecting heart failure in patients. Research conducted by the Trivandrum Heart-Failure Registry demonstrates that T2DM is a common comorbidity among hospitalized patients, accounting for 55 percent of cases. This marker is crucial in managing Type 2 Diabetes (T2DM) while re-evaluating the patient's treatment.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiac Marker Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Assure Tech (Hangzhou) Co., Ltd., Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biomérieux SA, Boditech Med Inc., Charles River Laboratories International, Inc., Cleerly, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche AG, HyTest Ltd., Laboratory Corporation of America Holdings, LightDeck Diagnostics, Merck KGaA, Natera, Inc., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics, QuidelOrtho Corporation, Randox Laboratories Ltd., Sekbio, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product- Instruments

  • Chemiluminescence
  • ELISA
  • Immunochromatography
  • Immunofluorescence
  • Reagents & Kits

Biomarker

  • BNP Or NT-ProBNP
  • Ceratine Kinase-MB
  • hs-CRP
  • Myoglobin
  • Troponin

Type of Testing

  • Laboratory Testing
  • Point-Of-Care Testing

Disease

  • Congestive Heart Failure
  • Myocardial Infarction

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cardiovascular diseases and need for effective diagnostics
5.1.1.2. Rise of point-of-care testing for cardiac markers worldwide
5.1.1.3. Initiatives encouraging early detection and screening of cardiovascular diseases
5.1.2. Restraints
5.1.2.1. Adverse recalls of cardiac marker testing products
5.1.3. Opportunities
5.1.3.1. Advancements in testing technologies and integration of new biomarkers
5.1.3.2. Shift toward personalized medicine and introduction of tailored cardiac marker testing
5.1.4. Challenges
5.1.4.1. Concerns associated with inaccuracy and limited specificity of cardiac marker testing
5.2. Market Segmentation Analysis
5.2.1. Product: Significance of diagnostic instruments in cardiac marker testing
5.2.2. Biomarker: Rising utilization of Troponin biomarker for cardiac assessment
5.2.3. Type of Testing: Increasing adoption of Point-of-Care testing
5.2.4. Disease: Extensive applications of cardiac marker testing in myocardial infarction
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cardiac Marker Testing Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
7. Cardiac Marker Testing Market, by Biomarker
7.1. Introduction
7.2. BNP Or NT-ProBNP
7.3. Ceratine Kinase-MB
7.4. hs-CRP
7.5. Myoglobin
7.6. Troponin
8. Cardiac Marker Testing Market, by Type of Testing
8.1. Introduction
8.2. Laboratory Testing
8.3. Point-Of-Care Testing
9. Cardiac Marker Testing Market, by Disease
9.1. Introduction
9.2. Congestive Heart Failure
9.3. Myocardial Infarction
10. Americas Cardiac Marker Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cardiac Marker Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cardiac Marker Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
13.3.2. NOWDx and AeenaDx Announce Merger
13.3.3. Pathkind Labs, Roche Diagnostics Partner to Release Cardiac Biomarker
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CARDIAC MARKER TESTING MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC MARKER TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC MARKER TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CARDIAC MARKER TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CERATINE KINASE-MB, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CERATINE KINASE-MB, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 79. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 82. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 83. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 84. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 85. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 86. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 87. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 88. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 89. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 92. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 93. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 94. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 95. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 96. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 97. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 98. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 133. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 136. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 137. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 138. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 139. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 140. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 141. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 142. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 143. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 146. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 147. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 148. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 149. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 150. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 151. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 152. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 163. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 166. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 167. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 168. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 169. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 170. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 171. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 172. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 173. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 183. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 193. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 213. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 214. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 223. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 226. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 227. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 228. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 229. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 230. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 231. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 232. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 233. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 234. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 255. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 256. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 257. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 258. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 259. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 260. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 261. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 262. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 263. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 264. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 265. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 268. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 269. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 270. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 271. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 272. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 273. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 274. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 275. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 278. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 279. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 280. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 281. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 282. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 283. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 284. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 285. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 288. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 289. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 290. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 291. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 292. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 293. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 294. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 295. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 296. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 297. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 298. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 299. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 300. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 301. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 302. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 303. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 304. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 305. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 315. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 318. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 319. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 320. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 321. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 322. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 323. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 324. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 325. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 326. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 327. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 328. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 335. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 336. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 337. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
TABLE 338. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
TABLE 340. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
TABLE 341. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
TABLE 342. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
TABLE 343. NIGE

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Assure Tech (Hangzhou) Co., Ltd.
  • Atlas Medical GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biomérieux SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Cleerly, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • HyTest Ltd.
  • Laboratory Corporation of America Holdings
  • LightDeck Diagnostics
  • Merck KGaA
  • Natera, Inc.
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Sekbio
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

Methodology

Loading
LOADING...

Table Information